Should I get whole exome sequencing for my Melanoma

Whole Exome Sequencing for Melanoma: What You Should Know

This is an important question, and the answer depends on your specific situation. Let me explain what the evidence shows and what questions to discuss with your care team.

What Testing IS Recommended for Melanoma

According to the NCCN Guidelines for Patients: Melanoma (2025), genetic testing for melanoma focuses on specific mutations rather than whole exome sequencing as a routine approach.

The key biomarker testing that's typically recommended includes:

BRAF Mutation Testing

• This is the most commonly tested mutation in melanoma
• BRAF mutations are found in about 40-50% of melanomas
• Why it matters: If you have a BRAF V600 mutation, you may be eligible for targeted therapy drugs like dabrafenib/trametinib, which specifically attack cancer cells with this mutation
• According to NCCN Guidelines, BRAF testing should be done if not already completed, especially for recurrent melanoma or advanced disease

Other Genetic Testing

• The guidelines mention testing for CDKN2A mutations (also called p16INK4A or MTS1), which is the most common gene mutation associated with hereditary melanoma risk
• Additional genetic testing may be needed if you have a family history of melanoma or other cancers

When Whole Exome Sequencing Might Be Considered

Whole exome sequencing (which sequences all protein-coding genes in your DNA) is not listed as a standard recommendation in the NCCN Guidelines. However, it might be relevant if:

• You're enrolled in a clinical trial testing new approaches
• Your tumor has unusual features that don't fit standard patterns
• Your care team suspects a hereditary cancer syndrome
• Standard biomarker testing hasn't provided clear treatment guidance

Questions to Ask Your Oncologist

1. "Do I have a BRAF mutation, and if so, what does that mean for my treatment options?"

2. "Based on my stage and type of melanoma, what genetic testing do you recommend for me?"

3. "Is whole exome sequencing appropriate for my situation, or are there specific mutations you want to test for?"

4. "Are there clinical trials available that might use broader genetic testing?"

5. "If I have a family history of melanoma or cancer, should I see a genetic counselor?"

The Bottom Line

The NCCN Guidelines recommend targeted genetic testing (particularly BRAF mutation testing) rather than whole exome sequencing as a standard approach for most melanoma patients. However, your oncologist may recommend broader testing based on your individual circumstances—such as your cancer stage, whether it's recurrent, family history, or if you're considering clinical trials.

Your care team will determine which testing makes sense for YOUR specific case based on the complete clinical picture, including your pathology report, imaging results, and treatment goals.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.